Medications

This measure details the percentage of PHO-enrolled population aged 5-44 years who are dispensed a short-acting beta-agonist (SABA)  in at least two quarters in a year and were not dispensed preventer in two or more quarters in the same year. 

People aged 5–44 regularly dispensed a short-acting beta agonist (SABA) who were not dispensed preventer anytime during the year, among PHO enrolled population. This indicator shows the number and percent of people who were dispensed SABA in at least two quarters in a year and not dispensed preventer in the same year. 

This indicator shows the number and percent of people aged 5 –44 years who were not regularly dispensed ICS in the four quarters after discharge for an admission with a primary diagnosis of asthma. Regular dispensing was defined as dispensing in two or more quarters in the year post discharge. This was calculated using the date of discharge and dividing the following 365 days into four quarters.  

People admitted in the previous year with a primary diagnosis of asthma (or wheeze for children; see denominator for codes) who did not receive a funded influenza vaccine in the year following discharge.

This indicator shows the number and percent of people with diabetes receiving dulaglutide regularly. Regular use was defined as dulaglutide dispensed in three or more quarters in a year.

This indicator shows the number and percent of people with diabetes receiving empagliflozin regularly. Regular use was defined as empagliflozin dispensed in three or more quarters in a year.

This indicator shows the number and percent of people with diabetes receiving vildagliptin regularly. Regular use was defined as vildagliptin dispensed in three or more quarters in a year.

This indicator shows the number and percent of people with diabetes receiving metformin regularly. Regular use was defined as metformin dispensed in three or more quarters in a year.